Low serum 25‐hydroxyvitamin D levels in migraine are not related to headache frequency: A case‐control study in patients with high‐frequency/chronic migraine
Headache: The Journal of Head and Face Pain · 2025
DOI: 10.1111/head.14901 ↗Kurz gefasst
Fachartikel in der Zeitschrift Headache: The Journal of Head and Face Pain, 2025. Verfasst von Marina Haro und 6 weiteren Autor:innen. Beteiligte Einrichtung: Service of Internal Medicine, University Hospital Marqués de Valdecilla, Universidad de Cantabria and Valdecilla Research Institute (IDIVAL), Santand…. Hauptthemen laut MEDLINE: Migraine Disorders, Vitamin D, Vitamin D Deficiency. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Instituto de Salud Carlos III (ISCIII), FEDER, Federación Española de Enfermedades Raras.
Abstract (Originalsprache)
Background
Serum 25‐hydroxyvitamin D (25[OH]D) concentrations have been shown to be low in patients with migraine, but results are controversial regarding the current role of vitamin D in migraine severity. Using a case–control design, we aimed to evaluate serum 25(OH)D levels in a group of females with high‐frequency episodic migraine/chronic migraine (HF/CM) and analyze its association with headache frequency and serum calcitonin gene–related peptide (CGRP) levels.
Methods
Serum 25(OH)D levels were measured in 97 females with HF/CM (age 48.9 ± 9.4 years) and 146 healthy females (47.4 ± 8.1 years). Participants taking vitamin D supplements were excluded. Serum concentrations of 25(OH)D were determined by electrochemiluminescence (Roche, Germany), and CGRP levels were measured by enzyme‐linked immunosorbent assay (Abbexa, UK).
Results
Mean 25(OH)D levels in females with HF/CM (median [interquartile range] 19.0 [13.0–24.5] ng/mL) were below the values considered for insufficiency or deficiency and significantly lower than controls (25.0 [19–29.8] ng/mL; p < 0.0001). Fifty (51.5%) patients with HF/CM had levels below 20 ng/mL. There was no significant association between vitamin D levels and monthly headache days (Spearman's rank correlation coefficient [rho]: −0.086; p = 0.404) or with serum α (rho: 0.114; p = 0.267) and β‐CGRP (rho: 0.113; p = 0.276) levels. Serum 25(OH)D levels in females with HF/CM with a minimum daily sunlight exposure were significantly higher than those without (23.0 [15.0–26.0] ng/mL vs. 14.0 [10.0–20.0] ng/mL; p < 0.001). Females with HF/CM who performed exercise had higher, albeit not significant, plasma 25(OH)D levels than those who did not (21.0 [15.5–28.0] ng/mL vs. 16.5 [12.0–24.0] ng/mL; p = 0.059).
Conclusions
Serum concentrations of 25(OH)D were low in many patients with HF/CM. Because there was no correlation with migraine frequency or serum CGRP levels, this deficiency seems to be a direct consequence of the migraine impact. Our data do not support either a relationship of 25(OH)D levels with migraine severity or the use of vitamin D supplements as a specific migraine treatment, although further studies are needed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Service of Internal Medicine, University Hospital Marqués de Valdecilla, Universidad de Cantabria and Valdecilla Research Institute (IDIVAL), Santander, Spain.
- Service of Neurology, University Hospital Marqués de Valdecilla, Universidad de Cantabria and Valdecilla Research Institute (IDIVAL), Santander, Spain.
ORCID-Profile: Marina Haro, Gabriel Gárate, José Luis Hernández, José Manuel Olmos, Vicente González-Quintanilla, Julio Pascual
Förderung
- Instituto de Salud Carlos III (ISCIII)
- FEDER
- Federación Española de Enfermedades Raras
Zitieren
APA
Haro, M., Gárate, G., Hernández, J. L., Olmos, J. M., Muñoz, M., González-Quintanilla, V., & Pascual, J. (2025). Low serum 25‐hydroxyvitamin D levels in migraine are not related to headache frequency: A case‐control study in patients with high‐frequency/chronic migraine. Headache: The Journal of Head and Face Pain. https://doi.org/10.1111/head.14901
Vancouver
Haro M, Gárate G, Hernández JL, Olmos JM, Muñoz M, González-Quintanilla V, et al. Low serum 25‐hydroxyvitamin D levels in migraine are not related to headache frequency: A case‐control study in patients with high‐frequency/chronic migraine. Headache: The Journal of Head and Face Pain. 2025. doi:10.1111/head.14901
BibTeX
@article{Haro2025,
author = {Haro, Marina and Gárate, Gabriel and Hernández, José Luis and Olmos, José Manuel and Muñoz, María and González-Quintanilla, Vicente and Pascual, Julio},
title = {Low serum 25‐hydroxyvitamin D levels in migraine are not related to headache frequency: A case‐control study in patients with high‐frequency/chronic migraine},
journal = {Headache: The Journal of Head and Face Pain},
year = {2025},
doi = {10.1111/head.14901}
}
EUVIMED